LIXT
Lixte Biotechnology Holdings, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Geordan G. Pursglove
IPO Date
2007-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Lixte Biotechnology Holdings, Inc.
CEO
Geordan G. Pursglove
IPO Date
2007-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 17 Apr 2026 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | A-Award | Acquired | 350,000 | $0.00 |
| 17 Apr 2026 | Pursglove Geordan Garrett | director, officer: CEO and Chairman of the Board | D-Return | Disposed | 350,000 | $2.83 |
| 17 Apr 2026 | Stazzone Peter | Chief Financial Officer | A-Award | Acquired | 50,000 | $0.00 |
| 17 Apr 2026 | Stazzone Peter | Chief Financial Officer | D-Return | Disposed | 50,000 | $4.45 |
| 17 Apr 2026 | Sawyer Jason David | director | A-Award | Acquired | 25,000 | $0.00 |
| 17 Apr 2026 | Sawyer Jason David | director | D-Return | Disposed | 25,000 | $3.59 |
| 17 Apr 2026 | Felix Lourdes | director | A-Award | Acquired | 25,000 | $0.00 |
| 17 Apr 2026 | Felix Lourdes | director | D-Return | Disposed | 25,000 | $4.05 |